GENEWIZ receives investment from OrbiMed for growth in its DNA sequencing, gene synthesis
Genomics services provider, GENEWIZ, continues to grow with new financing, but it is unclear how much was raised in the OrbiMed-led round.
Other diagnostic companies utilize regulatory loopholes, not just Theranos
Several diagnostic companies use the "laboratory developed test" loophole to avoid regulation and market tests without FDA approval, for better or worse.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.